Marc Belsky
2016 - Five Prime Therapeutics
In 2016, Marc Belsky earned a total compensation of $1.7M as Senior Vice President and Chief Financial Officer at Five Prime Therapeutics, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $92,450 |
|---|---|
| Non-Equity Incentive Plan | $165,000 |
| Option Awards | $818,436 |
| Salary | $361,667 |
| Stock Awards | $218,550 |
| Other | $6,000 |
| Total | $1,662,103 |
Belsky received $818.4K in option awards, accounting for 49% of the total pay in 2016.
Belsky also received $92.5K in bonus, $165K in non-equity incentive plan, $361.7K in salary, $218.6K in stock awards and $6K in other compensation.
Rankings
In 2016, Marc Belsky's compensation ranked 5,759th out of 14,075 executives tracked by ExecPay. In other words, Belsky earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,759 out of 14,075 | 59th |
Division Manufacturing | 2,086 out of 5,489 | 62nd |
Major group Chemicals And Allied Products | 675 out of 1,895 | 64th |
Industry group Drugs | 505 out of 1,538 | 67th |
Industry Pharmaceutical Preparations | 402 out of 1,176 | 66th |
Source: SEC filing on March 31, 2017.
Belsky's colleagues
We found five more compensation records of executives who worked with Marc Belsky at Five Prime Therapeutics in 2016.
2016
Lewis Williams
Five Prime Therapeutics
Chief Executive Officer
2016
Kevin Baker
Five Prime Therapeutics
Senior Vice President, Product Development
2016
Aron Knickerbocker
Five Prime Therapeutics
Chief Operating Officer
2016
Robert Sikorski
Five Prime Therapeutics
Chief Medical Officer
2016
Francis Sarena
Five Prime Therapeutics